Reports
Global Cytokine Market: By Type: Tumour Necrosis Factor - TNF, Interleukins - II, Interferons - IFN, Epidermal Growth Factor - EGF, Others; By Therapeutic Application: Cancer, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Cytokine Market Outlook
The global cytokine market is expected to grow in the forecast period of 2023-2028 at a CAGR of 6%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Prevalence of Diseases, such as Cancer and Skin Disorders Boosting the Industry Growth
Cytokines are known to play an essential role in many disease processes; they can be used in treating many disorders. An individual’s ability to fight off infection can be determined by measuring cytokine production. Cytokine are used as therapeutic agents in treating people with cancer and immunodeficiency disorders and those undergoing organ transplantation. Cytokine can enhance the vaccines’ effectiveness when mixed with a vaccine. They also act as fighting agents in our bodies. When they are released, they signal the immune system to do its job. Cytokine affects the growth of all blood cells and other cells that help the body's immune and inflammation responses. They also help boost anti-cancer activity in the body by sending signals that can help make abnormal cells die and normal cells live longer. The increasing prevalence of diseases like cancer and skin disorders is expected to drive the growth of the cytokine industry.
Cytokine: Market Segmentation
Cytokine refers to a group of small, short-lived proteins that are released by one cell to regulate the function of another cell, thereby serving as intercellular chemical messengers. Cytokine effect changes in cellular behaviour that are important in a number of physiological processes, including reproduction, growth and development, and injury repair.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market is divided into:
- Tumour Necrosis Factor - TNF
- Interleukins - II
- Interferons - IFN
- Epidermal Growth Factor - EGF
- Others
Based on therapeutic application, the market is divided into:
- Cancer
- Asthma and Airway Inflammation
- Arthritis
- Others
The EMR report looks into the regional markets of cytokine like North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Advancement of New Technologies to Aid the Growth of Cytokine Industry
Cytokine has proven to be effective in the treatment of cancer and may continue to play a major role in the development of cancer immunotherapy. Cloned cytokine has been used for the treatment of hepatitis C, hepatitis B, and many types of cancer. Cytokine is also effective for the treatment of a rare hereditary disease. Further, cytokines, when released in response to inflammation, infection, and immunity, can help restrict the growth of cancer. The therapeutic application of cytokine in the treatment of cancer is expected to hold the largest share of the market. This could be attributed to the increasing acceptance of cytokine in cancer therapy over the world. Moreover, the cytokine is generally used in R&D activities in the field of drug development and life sciences. The growing demand for cytokine for wound management and cancer therapeutics is expected to drive the growth of the market. The cytokine industry is anticipated to grow over the forecast period owing to the advancement of new technologies.
Key Industries Players in the Global Cytokine Market
The report presents a detailed analysis of the following key players in the global cytokine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Lonza Group Ltd.
- Abcam plc.
- Genscript Biotech Corporation
- Randox Laboratories Ltd.
- Others
The comprehensive report looks into macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapeutic Application, Regions |
| Breakup by Type | Tumour Necrosis Factor - TNF, Interleukins - II, Interferons - IFN, Epidermal Growth Factor - EGF, Others |
| Breakup by Therapeutic Application | Cancer, Asthma and Airway Inflammation, Arthritis, Others |
| Breakup by Regions | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles-Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | F. Hoffmann-La Roche Ltd, Merck KGaA, Lonza Group Ltd, Abcam plc., Genscript Biotech Corporation, Randox Laboratories Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Cytokine Market Analysis
8.1 Key Industry Highlights
8.2 Global Cytokine Historical Market (2018-2022)
8.3 Global Cytokine Market Forecast (2023-2028)
8.4 Global Cytokine Market by Type
8.4.1 Tumour Necrosis Factor - TNF
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Interleukins - II
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Interferons - IFN
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.4.4 Epidermal Growth Factor - EGF
8.4.4.1 Historical Trend (2018-2022)
8.4.4.2 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Cytokine Market by Therapeutic Application
8.5.1 Cancer
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Asthma and Airway Inflammation
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Arthritis
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Cytokine Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
9 North America Cytokine Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Cytokine Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Cytokine Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Cytokine Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Cytokine Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 F. Hoffmann-La Roche Ltd
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Merck KGaA
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Lonza Group Ltd
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Abcam plc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Genscript Biotech Corporation
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Randox Laboratories Ltd.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Cytokine Market: Key Industry Highlights, 2018 and 2028
2. Global Cytokine Historical Market: Breakup by Type (USD Million), 2018-2022
3. Global Cytokine Market Forecast: Breakup by Type (USD Million), 2023-2028
4. Global Cytokine Historical Market: Breakup by Therapeutic Application (USD Million), 2018-2022
5. Global Cytokine Market Forecast: Breakup by Therapeutic Application (USD Million), 2023-2028
6. Global Cytokine Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Cytokine Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Cytokine Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Cytokine Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Cytokine Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Cytokine Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Cytokine Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Cytokine Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Cytokine Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Cytokine Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Cytokine Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Cytokine Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Cytokine Market Structure
Key Questions Answered in the Report
The global cytokine market is projected to grow at a CAGR of 6% between 2023 and 2028.
The market is driven by the increasing prevalence of diseases such as cancer and skin disorders, growing demand for cytokine for wound management and cancer therapeutics and increasing disposable income.
The market is expected to be defined by the technological advancements in the industry.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The different type of cytokine available in the market are tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others.
The various therapeutic applications of cytokine is in diseases, such as cancer, asthma and airway inflammation, and arthritis, among others.
The leading players in this market are F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.
Analyst Review
The global cytokine market is driven by increasing prevalence of diseases, such as cancer and skin disorders. Aided by the technological advances in the industry, the market is expected to witness a further a growth in the forecast period of 2023-2028, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. The cytokine industry is divided on the basis of types into tumour necrosis factor – TNF, Interleukins – II, Interferons – IFN, and epidermal growth factor - EGF, among others. The market is segmented on the basis of therapeutic applications into cancer, asthma and airway inflammation, and arthritis, among others. The key players in the above industry include F. Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Abcam plc, Genscript Biotech Corporation, and Randox Laboratories Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER